Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Alicia Algeciras Schimnich"'
Autor:
Daniel J. Figdore, Heather J. Wiste, Joshua A. Bornhorst, Randall J. Bateman, Yan Li, Jonathan Graff‐Radford, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack Jr, Ronald C. Petersen, Alicia Algeciras‐Schimnich
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 16, Iss 1, Pp n/a-n/a (2024)
Abstract INTRODUCTION This study evaluated the performance of the Lumipulse plasma beta‐amyloid (Aβ) 42/40 and pTau181 compared to other assays to detect an abnormal amyloid‐positron emission tomography (PET). METHODS Plasma samples from cogniti
Externí odkaz:
https://doaj.org/article/58bfb3ece9c642f09b11f2a1ba46b37d
Autor:
Janina Krell‐Roesch, Isabella Zaniletti, Jeremy A. Syrjanen, Walter K. Kremers, Alicia Algeciras‐Schimnich, Jeffrey L. Dage, Argonde C. vanHarten, Julie A. Fields, David S. Knopman, Clifford R. Jack Jr, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 15, Iss 3, Pp n/a-n/a (2023)
Abstract INTRODUCTION We examined associations between plasma‐derived biomarkers of Alzheimer's disease (AD) and neuropsychiatric symptoms (NPS) in community‐dwelling older adults. METHODS Cross‐sectional study involving 1005 persons ≥50 year
Externí odkaz:
https://doaj.org/article/5c2a0d36932f4b889296ebf27547267f
Autor:
Megan Holdren, Rhianna Urban, Megan Hoenig, Dragana Milosevic, Lori Erickson, Alicia Algeciras-Schimnich, Stefan Grebe, Irina Bancos, William Young, Wei Shen, Sounak Gupta
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100079- (2023)
Externí odkaz:
https://doaj.org/article/838cb3a350704254ba6ec119071fba7d
Autor:
Jordan D. Marks, Jeremy A. Syrjanen, Jonathan Graff-Radford, Ronald C. Petersen, Mary M. Machulda, Michelle R. Campbell, Alicia Algeciras-Schimnich, Val Lowe, David S. Knopman, Clifford R. Jack, Prashanthi Vemuri, Michelle M. Mielke, for the Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background Total tau protein (T-Tau) and neurofilament light chain (NfL) have emerged as candidate plasma biomarkers of neurodegeneration, but studies have not compared how these biomarkers cross-sectionally or longitudinally associate with
Externí odkaz:
https://doaj.org/article/1c79f5778aa341c8afd4c26414d61b71
Autor:
Kittrawee Kritmetapak, Louis Losbanos, Taylor E. Berent, Susan L. Ashrafzadeh-Kian, Alicia Algeciras-Schimnich, Jolaine M. Hines, Ravinder J. Singh, Rajiv Kumar
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Hyperphosphatemia confers adverse cardiovascular outcomes, and commonly occurs in late-stage CKD. Fibroblast growth factor 7 (FGF7) is a phosphaturic peptide which decreases renal phosphate transport in vitro and in vivo. Serum FG
Externí odkaz:
https://doaj.org/article/442359481de8413eb53bf77f668481be
Autor:
Dror Shir, Michelle M. Mielke, Ekaterina I. Hofrenning, Timothy G. Lesnick, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Alicia Algeciras-Schimnich, Prashanthi Vemuri, Jonathan Graff-Radford
Publikováno v:
Journal of Alzheimer's Disease. 92:887-898
Background: The National Institute on Aging-Alzheimer’s Association Research Framework proposes defining Alzheimer’s disease by grouping imaging and fluid biomarkers by their respective pathologic processes. The AT(N) structure proposes several n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8365f9be01c4c6d6f6256eea82a3c63
https://doi.org/10.3233/jad-221015
https://doi.org/10.3233/jad-221015
Autor:
Michelle R. Campbell, Susan Ashrafzadeh‐Kian, Ronald C. Petersen, Michelle M. Mielke, Jeremy A. Syrjanen, Argonde C. vanHarten, Val J. Lowe, Clifford R. Jack Jr, Joshua A. Bornhorst, Alicia Algeciras‐Schimnich
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 13, Iss 1, Pp n/a-n/a (2021)
Abstract Introduction Measurement of amyloid beta (Aβ40 and Aβ42) and tau (phosphorylated tau [p‐tau] and total tau [t‐tau]) in cerebrospinal fluid (CSF) can be utilized to differentiate clinical and preclinical Alzheimer's disease dementia (AD
Externí odkaz:
https://doaj.org/article/cb856f97965d45e296a325ba90d10e17
Autor:
Anthony Maus, Erica M. Fatica, Robert Taylor, Bethany J. Larson, Alicia Algeciras-Schimnich, Ravinder J. Singh, Stefan K. Grebe
Publikováno v:
Journal of Proteome Research. 22:1322-1330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12f437541095c6b392e92e9eeab43af7
https://doi.org/10.1021/acs.jproteome.2c00829
https://doi.org/10.1021/acs.jproteome.2c00829
Autor:
Paola Ramos, Bethany Larson, Susan Ashrafzadeh-Kian, Nobuaki Ito, Hajime Kato, Joshua A. Bornhorst, Alicia Algeciras-Schimnich
Publikováno v:
Endocrine Practice. 29:193-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec195d1c1f3bd342455d79f21eb31065
https://doi.org/10.1016/j.eprac.2023.01.003
https://doi.org/10.1016/j.eprac.2023.01.003
Autor:
Clifford R Jack, Heather J Wiste, Alicia Algeciras-Schimnich, Dan J Figdore, Christopher G Schwarz, Val J Lowe, Vijay K Ramanan, Prashanthi Vemuri, Michelle M Mielke, David S Knopman, Jonathan Graff-Radford, Bradley F Boeve, Kejal Kantarci, Petrice M Cogswell, Matthew L Senjem, Jeffrey L Gunter, Terry M Therneau, Ronald C Petersen
Publikováno v:
Brain. 146:2029-2044
Staging the severity of Alzheimer’s disease pathology using biomarkers is useful for therapeutic trials and clinical prognosis. Disease staging with amyloid and tau PET has face validity; however, this would be more practical with plasma biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::067e3e4251103f4f858139799f5bb476
https://doi.org/10.1093/brain/awad042
https://doi.org/10.1093/brain/awad042